Supplemental Figure 3 from BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer

Authors :: Arul M. Chinnaiyan
Felix Y. Feng
Shaomeng Wang
Nora M. Navone
Stephen R. Plymate
June Escara-Wilke
Ingrid J. Apel
Pranathi M. Krishnamurthy
Vijaya L. Dommeti
Kari Wilder-Romans
Irfan A. Asangani
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: De-recruitment of BRD2/3/4 from the SRSF1 and U2AF1 promoter by JQ1.

Full Text Access

Tools